SLC5A2 and type 2 diabetes mellitus: Early studies in rats reported beneficial effects of inhibition of the renal glucose reabsorption by phlorizin on the glucose tolerance and prompted the introduction of SGLT2 inhibitors as means to lower glucose in patients with type 2 diabetes.